The effects of intravenous propranolol were studied in nine patients with ischemic heart disease during cardiac catheterization. 
W ITH THE development of pharmacologic agents capable of blocking betaadrenergic receptor sites, interest in the effects of the sympathetic nervous system on myocardial and coronary dynamics has intensified. The negative chronotropic action of these drugs was recognized to be of clinical value in a variety of cardiac arrhythmias.1
From the Cardiopulmonary Branch, Department of Medicine, U. S. Naval Hospital, Philadelphia, Pennsylvania. Presented at the annual meeting of the American Heart Association in San Francisco, California, October 20 to 22, 1967. The opinions expressed herein are those of the authors and cannot be construed as reflecting the views of the Navy Department or of the Naval Service at large. 250 Reduction of cardiac sympathetic activity by bilateral cervicothoracic sympathectomy2 or stellate ganglion block3 has produced beneficial effects in patients with angina. On the basis of these observations, a beta blocking agent, such as propranolol, was thought likely to be useful in controlling myocardial oxygen utilization. This consideration has led to a number of clinical trials in patients with angina pectoris.4'5 Preliminary observations, in general, have shown an increased exercise tolerance together with reduction in the frequency and severity of angina.
The hemodynamic effects of beta-adrenergic blockade (propranolol) in patients with coronary heart disease complicated by angina pectoris constitute the subject of this investigation. Special emphasis is placed on the Circulation, Volume XXXVIII, August 1968 manner in which propranolol alters left ventricular function at rest as well as during ex- ercise.
Methods
The study was The hemodynamic data at rest and during exercise, before and after propranolol are presented in tables 2 and 3. All nine patients developed angina during exercise prior to beta blockade. The patients were divided into two groups, depending on their pain response to exercise after propranolol. Group I, the angina group, were those patients in whom propranolol did not completely relieve angina. In these patients (five), exertional angina recurred but generally was delayed in appearance and less severe. Group II, the angina-free group were the remaining four patients in whom propranolol was totally effective in preventing exertional angina.
The differences between group I and group II were not statistically significant. However, both groups were small in number and an overlap of values may have resulted from the wide range of work loads imposed within each group. On the other hand, all observed changes following propranolol in the entire group were statistically significant (P < 0.01).
Electrocardiographic Changes
The electrocardiographic alterations were confined to ST-segment depressions, which were observed in all but two patients during the control exercise. A separate ergometry study prior to cardiac catheterization demonstrated ST-segment depression of 1.0 mm or greater in all subjects 2 minutes after exercise. After propranolol, both the exercise and postexercise electrocardiogram changes in the ST segment were less marked in all nine cases ( fig. 1 ).
Systolic Pressure and Heart Rate
The response of heart rate and left ventricular systolic pressure to exercise prior to propranolol was quite variable, undoubtedly related to the wide range of work levels. The heart rate increased an average of 40 beats a minute (53%) and left ventricular systolic Figure 2 Propranolol produced small but significant reductions in left ventricular systolic pressure and heart rate.
Left Ventricular First Derivative (LV dp/dt)
Left ventricular first-derivative mean value at rest was 1,580 mm Hg per second and rose to 2,620 mm Hg per second with exercise. This represents a change of 60%. Propranolol resulted in a marked decline in LV dp/dt in both groups at rest and during exercise ( fig.  3) . Again, the postpropranolol exercise data demonstrated a distinct difference between groups I and II. When angina appeared, an overall increase of 55% in LV dp/ dt was observed, although the absolute peak value reached was considerably less than control exercise levels. In those patients in whom angina was prevented, the average peak LV dp/ dt attained during exercise was equal to control resting values. Moreover, the change in LV dp/dt induced by exercise in this group was minimal (+14% Figure 3 With the administration of propranolol, a decrease in the left ventricular first derivative occurred at rest and during exercise. The reduction of the exercise derivative was more evident in the angina-free group. The jects as well as in patients with coronary artery disease. Similar hemodynamic alterations were found. In addition, they noted a reduced myocardial oxygen consumption, which they attributed to a reduction in heart rate and ventricular systolic force.
The present investigation showed comparable decreases in resting left ventricular systolic pressure, cardiac output, and left ventricular work while heart rate fell but slightly. In addition, propranolol caused a reduction in left ventricular first derivative (25%), but failed to alter appreciably left ventricular end-diastolic pressure or pulmonary artery pressure.
During exercise in normal subjects, Epstein and associates12 demonstrated that betaadrenergic blockade produced a decline in heart rate (-21%), cardiac output (-16%), mean arterial pressure (-7%), and left ventricular work (-21%). In our group of patients with ischemic heart disease, propranolol altered the exercise response by reducing the left ventricular first derivative (-33%), cardiac output (-21%), left ventricular work (-30%), left ventricular systolic pressure (-7%), and heart rate (-11%), while increasing pulmonary artery pressure (+10%); a marked elevation in left ventricular end-diastolic pressure was noted both before and after propranolol. In short, propranolol did not alter the rise in the left ventricular end-diastolic pressure, which occurred during the control exercise state ( fig. 7) .
Angina, which developed in all nine patients during control exercise, did not appear in four after propranolol, although the exercise workload was identical. In the remaining five patients, angina was generally less intense, delayed in onset, and of shorter duration. The postexercise electrocardiogram demonstrated less ischemic ST depression in all nine cases after propranolol, regardless of the appearance of angina.
Following beta-adrenergic blockade, the response to exercise in the four angina-free patients was compared with five patients with angina and disclosed some differences. Angina corresponded with an increase in left EXERCISE Figure 7 Representative changes of heart rate, systolic pressure, and left ventricular first derivative during exercise following propranolol. ventricular dp/ dt and heart rate of 55% and 40%, respectively. The angina-free group had a diminished response to exercise, that is, left ventricular dp/dt increased 14% and heart rate 32%. 27, 28 These include decreased coronary blood flow, widened A-V oxygen difference, and increased coronary vascular resistance. Recently Robin and associates18 have studied myocardial metabolism in patients with coronary artery disease before and after propranolol. Their data indicate a negative reduction-oxidation potential or anaerobic metabolism in many of their patients at rest. After administration of propranolol, they found a decrease in the redox potential or further myocardial hypoxia. These findings are obviously inconsistent with the relief of chest pain and reduced electrocardiographic ischemia clinically observed after the drug. Further clarification of the metabolic changes produced by propranolol during angina would appear warranted.
Recent evidence points to the role of left ventricular first derivative, both as a reliable measure of myocardial contractility and as a major determinant of myocardial oxygen consumption.29 Our findings indicate that the beneficial action of propranolol in angina derives predominantly from suppression of contractility (LV dp/dt) and, to a lesser extent, from its negative chronotropic action. 
